Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
about
MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolismMagnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.Hepatocellular ballooning in NASH.Inflammation in nonalcoholic steatohepatitis.Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver diseaseObesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly.Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation.Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.Treatment strategies in nonalcoholic fatty liver disease.Histological assessment of non-alcoholic fatty liver disease.Intermediate filament cytoskeleton of the liver in health and diseaseIncreased production of sonic hedgehog by ballooned hepatocytes.Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.Non-alcoholic fatty liver disease and diabetes.CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation.Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.Quantification of liver fat with magnetic resonance imaging.Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD).Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease.Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD.Effect of Sinai san decoction on the development of non-alcoholic steatohepatitis in rats.Hepatic steatosis, fibrosis, and cancer in elderly cadavers.Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.Effect of gadolinium on hepatic fat quantification using multi-echo reconstruction technique with T2* correction and estimation.Quantification of Liver Fat with mDIXON Magnetic Resonance Imaging, Comparison with the Computed Tomography and the Biopsy.Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease.An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver diseaseNonalcoholic fatty liver disease: different classifications concordance and relationship between degrees of morphological features and spectrum of the disease
P2860
Q24629354-E6354D3F-AB93-4374-846B-98C36CD19BA6Q30418856-A11D7724-8D44-48B0-B205-BDE82748369BQ30430478-8C3BB8EC-2FDF-4FC1-A1F6-0F264C17A3ABQ30453231-16D7F6D9-6C07-47DF-926E-35A5C1DA6D66Q34021973-3CCF63A8-8021-4A75-A175-270555F8DF64Q34207748-244A7179-C8AA-44DB-B661-6BB6D9D3D9DDQ34252404-5D0FBB75-8552-455A-A9C0-0901F7A8A8AFQ34560114-6667C09A-9957-4FA8-B442-CD27221E20A4Q35039525-102A77E1-D7D8-4D49-BFE4-DEFE21E1114AQ35200808-B6D49850-C6C6-42F6-92C8-9CCAB83BC061Q35209849-CF365EEC-47C0-41B3-8469-97196E65F03DQ35233535-54CE31DC-1BAE-46A2-9707-C3CD9CF81A38Q35406503-5C8267F2-4154-41F6-809F-A81267540322Q36104827-278DE7FC-F689-42B1-9168-06A02AF0949CQ36304115-2D7476E3-494B-415C-87B6-DED1D96E7E59Q36634377-C84DE6FF-26F2-406B-B8F0-E7713EEDC595Q36661678-DA8AD762-3CA1-42D2-8D83-32713E2411A4Q36773522-A4954A3C-2A1E-462B-9D89-F1C103173A6EQ36791363-8AACB4FB-210C-433B-968A-D7845F63C3EEQ37091659-33B207B3-F22E-4F7D-8F4B-F60925A9EAADQ37228136-7A20614C-133F-4D13-98D4-4342B2F832B7Q37405449-7EFBD29D-F2E4-4805-AAF5-61A6BD81F55CQ37678998-6FCECFB1-7A99-48A4-90FB-2D0DA9927340Q37693238-01AD714A-0CC2-4174-AAB2-11D45E98803BQ37811338-C19A9C18-84A8-478C-85EC-45D2A6B4C09FQ37858449-5879773C-33AE-4C0A-B41D-BF00BCFEE53DQ38165139-211696D6-7C3B-42CD-98DD-2FE3AC0E716FQ38175368-D9F7432D-5E3D-4D0E-9203-184B8B6A9868Q38996795-B239EEBE-0B02-4789-A755-5175D70C2A8DQ41889139-EA7ADF3B-7CEE-4AC1-BB13-0EAB3FDCA3A3Q43048500-C5BE07B9-FF1A-458A-A813-19C0709C4031Q44083275-C3E3E4A2-E53C-47B0-8D50-D4CEB7529D8AQ46515459-2FD0328E-194E-4F8D-983D-22EF9C2D39A4Q48737176-125B24AA-0BEB-4923-8FEA-EEFBEABFC624Q50150871-D4D0DDE6-5BE8-44F8-AE4C-1759FD9A2EEDQ53085676-51381386-116F-4E54-8138-E2C697530880Q54221416-A7B74369-0FF4-4540-892E-1589D624D798Q55401392-AD9BE256-D9B4-461D-A43E-5AB099AED5E3Q58748144-20BC5D8A-FAE2-4A16-9F9F-0639F765ECC9Q59044440-612B6731-6481-4B2B-98BD-A908D69430A4
P2860
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@ast
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@en
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@nl
type
label
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@ast
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@en
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@nl
prefLabel
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@ast
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@en
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
@nl
P2093
P1433
P1476
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
@en
P2093
Arthur J McCullough
Christi A Matteoni
Navdeep Boparai
Terry Gramlich
Zobair M Younossi
P304
P356
10.1016/J.HUMPATH.2003.09.018
P407
P577
2004-02-01T00:00:00Z